Nutritionists Recommend That Healthy Foods.
Does it surely cost more to spike to a healthy diet? The answer is yes, but not as much as many people think, according to a new study. The digging review combined the results of 27 studies from 10 different countries that compared the sell for of healthy and unhealthy diets. The verdict? A diet rich in fruits, vegetables, nuts and fish costs about a man about $1,50 more per day - or $550 per year - compared to a senate high in processed grains and meats, fat, sugar and convenience foods. By and large, protein drove the bonus increases.
Researchers found that nourishing proteins - think a portion of boneless skinless chicken breast - were 29 cents more valuable per serving compared to less healthy sources, like a fried chicken nugget. The workroom was published online Dec 5, 2013 in the journal BMJ Open. "For many low-income families, this could be a earnest barrier to healthy eating," said review author Mayuree Rao. She is a junior research fellow in the department of epidemiology at the Harvard School of Public Health, in Boston.
For example, a house of four that is following the USDA's thrifty eating contemplate has a weekly food budget of about $128. An extra $1,50 per for each being in the family a day adds up to $42 for the week, or about 30 percent of that family's total prog tab. Rao says it's wouldn't be such a big difference for many middle-class families, though. She said that "$1,50 is about the quotation of a cup of coffee and really just a drop in the bucket when you consider the billions of dollars burnt- every year on diet-related chronic diseases".
Researchers who weren't involved in the review had wealth to say about its findings. "I am thinking that a mean difference in cost of $1,50 per woman per day is very substantial," said Adam Drewnowski, director of the nutritional sciences program at the University of Washington, in Seattle. He has compared the tariff of healthy versus unhealthy diets. Drewnowski said that at an further $550 per year for 200 million people would top the entire annual budget for food assistance in the United States.
Dr Hilary Seligman, an aide-de-camp professor of medicine at the University of California, San Francisco, said healthy food can be extravagant for families in ways that go beyond its cost at the checkout. For that reason the strict cost comparison in this judge probably underestimates the true burden to a person's budget. For example, she pointed out that subjects in poor neighborhoods that lack big grocery stores may not be able to afford the gas to drive to buy late fruits and vegetables.
They may work several jobs and not have time to prep foods from scratch. "To consume a healthy diet on a very low income requires an extraordinary amount of time. It's doable, but it's really, real hard work. These studies just don't take things disposed to that into account". Still, Melissa Joy Dobbins, a registered dietitian and a spokesperson for the Academy of Nutrition and Dietetics, said the examine should reassure many consumers that "eating healthy doesn't have to charge more".
She said the academy recommends the following nutrient-rich, budget-friendly foods - Beans. They equip fiber, protein, iron and zinc. Dry beans are cheaper but need to be soaked. Canned beans are more ready but should be rinsed to reduce the salt content. Canned beans are about 13 cents per quarter-cup serving. Dried beans set about 9 cents per ounce.
Sunday, 29 October 2017
An Approved Vaccine To Treat Prostate Cancer Has Few Side Effects
An Approved Vaccine To Treat Prostate Cancer Has Few Side Effects.
The newly approved medical prostate cancer vaccine, Provenge, is innocuous and has few position effects, a new study finds. In April, the US Food and Drug Administration approved the vaccine for use in men with advanced prostate cancer who had failed hormone therapy. "Provenge was approved based on both safeness and clinical data," said head researcher Dr Simon J Hall, chairman of urology at Mount Sinai Medical Center in New York City.
This sanctuary data shows that there are very limited side effects. The gain of the vaccine for patients with metastatic hormone-resistant prostate cancer is that it has fewer side slang shit than chemotherapy, which is the only other treatment option for these patients. In addition, Provenge has improved survival over chemotherapy.
The ordinary survival time for men given Provenge is 4,5 months, although some patients saw their lives extended by two to three years. "This is a newly close by treatment, with very limited surface effects, compared to anything else that a man would be considering in this state". Hall was to present the results on Monday at the American Urological Association annual assignation in San Francisco.
Data from four phase 3 trials, which included 904 men randomized to either Provenge or placebo, showed the vaccine extended survival, improved supremacy of freshness and had only mild side effects. In fact, more than 83 percent of the men who received Provenge were able to do appear as activities without any restrictions, the researchers noted.
The newly approved medical prostate cancer vaccine, Provenge, is innocuous and has few position effects, a new study finds. In April, the US Food and Drug Administration approved the vaccine for use in men with advanced prostate cancer who had failed hormone therapy. "Provenge was approved based on both safeness and clinical data," said head researcher Dr Simon J Hall, chairman of urology at Mount Sinai Medical Center in New York City.
This sanctuary data shows that there are very limited side effects. The gain of the vaccine for patients with metastatic hormone-resistant prostate cancer is that it has fewer side slang shit than chemotherapy, which is the only other treatment option for these patients. In addition, Provenge has improved survival over chemotherapy.
The ordinary survival time for men given Provenge is 4,5 months, although some patients saw their lives extended by two to three years. "This is a newly close by treatment, with very limited surface effects, compared to anything else that a man would be considering in this state". Hall was to present the results on Monday at the American Urological Association annual assignation in San Francisco.
Data from four phase 3 trials, which included 904 men randomized to either Provenge or placebo, showed the vaccine extended survival, improved supremacy of freshness and had only mild side effects. In fact, more than 83 percent of the men who received Provenge were able to do appear as activities without any restrictions, the researchers noted.
Friday, 27 October 2017
Dentists Are Reminded Of Preventing Dental Disease
Dentists Are Reminded Of Preventing Dental Disease.
Too many Americans dearth access to remedy dental care, a new study reports, and large differences abide among racial and ethnic groups. For the study, researchers analyzed give survey data collected from nearly 650000 middle-aged and older adults between 1999 and 2008. The investigators found that the hundred who received preventive dental care increased during that time. However, 23 percent to 43 percent of Americans did not take home preventive dental care in 2008, depending on competition or ethnicity.
Rates of preventive care were 77 percent for Asian Americans, 76 percent for whites, 62 percent for Hispanics and Native Americans, and 57 percent for blacks, the results showed. The bookwork was published online Dec 17, 2013 in the register Frontiers in Public Health. Factors such as income, tuition and having health insurance explained the differences in access to prevention dental care among whites and other racial groups except blacks, according to a record book news release.
Too many Americans dearth access to remedy dental care, a new study reports, and large differences abide among racial and ethnic groups. For the study, researchers analyzed give survey data collected from nearly 650000 middle-aged and older adults between 1999 and 2008. The investigators found that the hundred who received preventive dental care increased during that time. However, 23 percent to 43 percent of Americans did not take home preventive dental care in 2008, depending on competition or ethnicity.
Rates of preventive care were 77 percent for Asian Americans, 76 percent for whites, 62 percent for Hispanics and Native Americans, and 57 percent for blacks, the results showed. The bookwork was published online Dec 17, 2013 in the register Frontiers in Public Health. Factors such as income, tuition and having health insurance explained the differences in access to prevention dental care among whites and other racial groups except blacks, according to a record book news release.
Wednesday, 25 October 2017
New Promise Against Certain Types Of Lung Cancer
New Promise Against Certain Types Of Lung Cancer.
An theoretical cancer anaesthetize is proving effective in treating the lung cancers of some patients whose tumors convey a certain genetic mutation, new studies show. Because the mutation can be hand over in other forms of cancer - including a rare form of sarcoma (cancer of the soft tissue), babyhood neuroblastoma (brain tumor), as well as some lymphomas, breast and colon cancers - researchers break they are hopeful the drug, crizotinib, will prove effective in treating those cancers as well. In one study, researchers identified 82 patients from among 1500 patients with non-small-cell lung cancer, the most general type of lung malignancy, whose tumors had a mutation in the anaplastic lymphoma kinase (ALK) gene.
Crizotinib targets the ALK "driver kinase," or protein, blocking its pursuit and preventing the tumor from growing, explained contemplate co-author Dr Geoffrey Shapiro, director of the Early Drug Development Center and fellow-worker professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, Boston. "The cancer apartment is actually addicted to the activity of the protein for its evolution and survival. It's totally dependent on it. The idea is that blocking that protein can fag the cancer cell".
In 46 patients taking crizotinib, the tumor shrunk by more than 30 percent during an normal of six months of taking the drug. In 27 patients, crizotinib halted rise of the tumor, while in one patient the tumor disappeared.
The drug also had few side effects. The most common was merciful gastrointestinal symptoms. "These are very positive results in lung cancer patients who had received other treatments that didn't livelihood or worked only briefly. The bottom line is that there was a 72 percent chance the tumor would shrivel or remain stable for at least six months".
The study is published in the Oct 28, 2010 proclamation of the New England Journal of Medicine. In recent years, researchers have started to ruminate of lung cancer less as a single disease and more as a group of diseases that rely on established genetic mutations called "driver kinases," or proteins that enable the tumor cells to proliferate.
That has led some researchers to zero in on developing drugs that target those specific abnormalities. "Being able to govern those kinases and disrupt their signaling is evolving into a very successful approach".
An theoretical cancer anaesthetize is proving effective in treating the lung cancers of some patients whose tumors convey a certain genetic mutation, new studies show. Because the mutation can be hand over in other forms of cancer - including a rare form of sarcoma (cancer of the soft tissue), babyhood neuroblastoma (brain tumor), as well as some lymphomas, breast and colon cancers - researchers break they are hopeful the drug, crizotinib, will prove effective in treating those cancers as well. In one study, researchers identified 82 patients from among 1500 patients with non-small-cell lung cancer, the most general type of lung malignancy, whose tumors had a mutation in the anaplastic lymphoma kinase (ALK) gene.
Crizotinib targets the ALK "driver kinase," or protein, blocking its pursuit and preventing the tumor from growing, explained contemplate co-author Dr Geoffrey Shapiro, director of the Early Drug Development Center and fellow-worker professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, Boston. "The cancer apartment is actually addicted to the activity of the protein for its evolution and survival. It's totally dependent on it. The idea is that blocking that protein can fag the cancer cell".
In 46 patients taking crizotinib, the tumor shrunk by more than 30 percent during an normal of six months of taking the drug. In 27 patients, crizotinib halted rise of the tumor, while in one patient the tumor disappeared.
The drug also had few side effects. The most common was merciful gastrointestinal symptoms. "These are very positive results in lung cancer patients who had received other treatments that didn't livelihood or worked only briefly. The bottom line is that there was a 72 percent chance the tumor would shrivel or remain stable for at least six months".
The study is published in the Oct 28, 2010 proclamation of the New England Journal of Medicine. In recent years, researchers have started to ruminate of lung cancer less as a single disease and more as a group of diseases that rely on established genetic mutations called "driver kinases," or proteins that enable the tumor cells to proliferate.
That has led some researchers to zero in on developing drugs that target those specific abnormalities. "Being able to govern those kinases and disrupt their signaling is evolving into a very successful approach".
Wednesday, 18 October 2017
Stents May Be Efficient Defense Against Stroke
Stents May Be Efficient Defense Against Stroke.
Both stents and stuffy surgery appear to be equally conspicuous in preventing strokes in people whose carotid arteries are blocked, according to investigating presented Friday at the American Stroke Association's annual meeting in San Antonio. However, a instant stents-versus-surgery trial, published Thursday in The Lancet, seemed to give surgery better marks, so the jury may still be out on which propose to is better in shielding patients from stroke.
So "I think both procedures are noteworthy and I'm happy to say we have two good options to treat patients," said Dr Wayne M Clark, professor of neurology and supervisor of the Oregon Stroke Center, Oregon Health Sciences University in Portland, and a co-author of the soothe association study. "I consider the ASA trial is really a positive for both stenting and surgery," said Dr Craig Narins, collaborator professor of medicine at the University of Rochester Medical Center in New York, who was not confused with the study. "I think this is going to change the way that physicians look at carotid artery disease."
That study, the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), was funded by the US National Institute of Neurological Disorders and Stroke and Abbott, which makes the carotid stents. "There has been a lot of skepticism about the facility of stenting to counterpart surgery and this venture pretty nicely shows that it does matched it overall".
But the findings from CREST need to be squared with the second trial, the International Carotid Stenting Study (ICSS). That European fling found that surgery remained superior to stenting in the short-term, and stenting did not appear to be as permissible as surgery. "They're very similar studies, although the European [ICSS] over didn't use embolic protection devices which are the standard of care in the US That could have skewed the results".
Embolic guard devices are tiny parachute-like devices placed downstream from a stent to safely catch on dislodged materials. Nevertheless "nothing is going to change overnight. It's a sea variety because surgery has been the standard of care for so long. This is very positive for stenting but the European trial inserts a note of caution."
In carotid endarterectomy (CEA) surgery, doctors bark away the built-up plaque that is causing a narrowing of the artery supplying blood to the brain. In contrast, the stenting wont involves inserting a wire lattice device to prop the artery open. Carotid artery infirmity is one of the leading causes of stroke and occurs when the arteries leading to the brain become blocked.
Both stents and stuffy surgery appear to be equally conspicuous in preventing strokes in people whose carotid arteries are blocked, according to investigating presented Friday at the American Stroke Association's annual meeting in San Antonio. However, a instant stents-versus-surgery trial, published Thursday in The Lancet, seemed to give surgery better marks, so the jury may still be out on which propose to is better in shielding patients from stroke.
So "I think both procedures are noteworthy and I'm happy to say we have two good options to treat patients," said Dr Wayne M Clark, professor of neurology and supervisor of the Oregon Stroke Center, Oregon Health Sciences University in Portland, and a co-author of the soothe association study. "I consider the ASA trial is really a positive for both stenting and surgery," said Dr Craig Narins, collaborator professor of medicine at the University of Rochester Medical Center in New York, who was not confused with the study. "I think this is going to change the way that physicians look at carotid artery disease."
That study, the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), was funded by the US National Institute of Neurological Disorders and Stroke and Abbott, which makes the carotid stents. "There has been a lot of skepticism about the facility of stenting to counterpart surgery and this venture pretty nicely shows that it does matched it overall".
But the findings from CREST need to be squared with the second trial, the International Carotid Stenting Study (ICSS). That European fling found that surgery remained superior to stenting in the short-term, and stenting did not appear to be as permissible as surgery. "They're very similar studies, although the European [ICSS] over didn't use embolic protection devices which are the standard of care in the US That could have skewed the results".
Embolic guard devices are tiny parachute-like devices placed downstream from a stent to safely catch on dislodged materials. Nevertheless "nothing is going to change overnight. It's a sea variety because surgery has been the standard of care for so long. This is very positive for stenting but the European trial inserts a note of caution."
In carotid endarterectomy (CEA) surgery, doctors bark away the built-up plaque that is causing a narrowing of the artery supplying blood to the brain. In contrast, the stenting wont involves inserting a wire lattice device to prop the artery open. Carotid artery infirmity is one of the leading causes of stroke and occurs when the arteries leading to the brain become blocked.
Monday, 9 October 2017
People With Epilepsy Have Increased Risk Of Mortality
People With Epilepsy Have Increased Risk Of Mortality.
People with infancy epilepsy who maintain to have seizures into adolescence and beyond face a significantly higher risk of death than proletariat who've never had epilepsy, new research suggests. In a study that followed 245 children for 40 years following their epilepsy diagnosis, researchers found that 24 percent died during that age period. That's a proportion of death that's three times as high as would be expected for people without epilepsy who were of a like age and sex.
And "In those people with childhood-onset epilepsy, those who do not outgrow their seizures have a substantially higher mortality evaluate over many years," said study senior author Dr Shlomo Shinnar, top dog of the Comprehensive Epilepsy Management Center at the Children's Hospital of Montefiore in New York City. But the danger to any individual in any given year is still less than 1 percent.
And the good news from the deliberate over is that "once you have seizure remission, mortality rates are similar to people without epilepsy ". The findings are published in the Dec 23, 2010 subject of the New England Journal of Medicine.
Epilepsy is a ailment of the brain caused by abnormal signaling messages from nerve cell to nerve cell, according to the US National Institute of Neurological Diseases and Stroke. Those anomalous signals can cause bizarre sensations, muscle spasms, seizures and even a loss of consciousness.
The most serious complication that occurs more often in common man with epilepsy is sudden unexplained death. However, little is known about why this is so. The contemporary study included 245 children living in Finland who were diagnosed with epilepsy in 1964. The children were followed prospectively for 40 years, and in most cases, when a eradication occurred, an autopsy was performed.
People with infancy epilepsy who maintain to have seizures into adolescence and beyond face a significantly higher risk of death than proletariat who've never had epilepsy, new research suggests. In a study that followed 245 children for 40 years following their epilepsy diagnosis, researchers found that 24 percent died during that age period. That's a proportion of death that's three times as high as would be expected for people without epilepsy who were of a like age and sex.
And "In those people with childhood-onset epilepsy, those who do not outgrow their seizures have a substantially higher mortality evaluate over many years," said study senior author Dr Shlomo Shinnar, top dog of the Comprehensive Epilepsy Management Center at the Children's Hospital of Montefiore in New York City. But the danger to any individual in any given year is still less than 1 percent.
And the good news from the deliberate over is that "once you have seizure remission, mortality rates are similar to people without epilepsy ". The findings are published in the Dec 23, 2010 subject of the New England Journal of Medicine.
Epilepsy is a ailment of the brain caused by abnormal signaling messages from nerve cell to nerve cell, according to the US National Institute of Neurological Diseases and Stroke. Those anomalous signals can cause bizarre sensations, muscle spasms, seizures and even a loss of consciousness.
The most serious complication that occurs more often in common man with epilepsy is sudden unexplained death. However, little is known about why this is so. The contemporary study included 245 children living in Finland who were diagnosed with epilepsy in 1964. The children were followed prospectively for 40 years, and in most cases, when a eradication occurred, an autopsy was performed.
Tuesday, 3 October 2017
How Many Doctors Will Tell About The Incompetence Of Colleagues
How Many Doctors Will Tell About The Incompetence Of Colleagues.
A philanthropic inquiry of American doctors has found that more than one-third would hesitate to turn in a ally they thought was incompetent or compromised by substance abuse or mental health problems. However, most physicians agreed in proposition that those in charge should be told about "bad" physicians. As it stands, said Catherine M DesRoches, auxiliary professor at the Mongan Institute for Health Policy at Massachusetts General Hospital and Harvard Medical School in Boston, "self-regulation is our best alternative, but these findings suggest that we honestly demand to strengthen that. We don't have a good alternative system".
DesRoches is lead author of the study, which appears in the July 14 come of the Journal of the American Medical Association. The American Medical Association (AMA) and other veteran medical organizations hold that "physicians have an ethical obligation to report" impaired colleagues. Several states also have essential reporting laws, according to background information in the article.
To assess how the widely known system of self-regulation is doing, these researchers surveyed almost 1900 anesthesiologists, cardiologists, pediatricians, psychiatrists and forebears medicine, general surgery and internal medicine doctors. Physicians were asked if, within the recent three years, they had had "direct, personal knowledge of a physician who was impaired or inexpert to practice medicine" and if they had reported that colleague.
Of 17 percent of doctors who had direct awareness of an incompetent colleague, only two-thirds actually reported the problem, the survey found. This without considering the fact that 64 percent of all respondents agreed that physicians should report impaired colleagues. Almost 70 percent of physicians felt they were "prepared" to account such a problem, the study authors noted.
A philanthropic inquiry of American doctors has found that more than one-third would hesitate to turn in a ally they thought was incompetent or compromised by substance abuse or mental health problems. However, most physicians agreed in proposition that those in charge should be told about "bad" physicians. As it stands, said Catherine M DesRoches, auxiliary professor at the Mongan Institute for Health Policy at Massachusetts General Hospital and Harvard Medical School in Boston, "self-regulation is our best alternative, but these findings suggest that we honestly demand to strengthen that. We don't have a good alternative system".
DesRoches is lead author of the study, which appears in the July 14 come of the Journal of the American Medical Association. The American Medical Association (AMA) and other veteran medical organizations hold that "physicians have an ethical obligation to report" impaired colleagues. Several states also have essential reporting laws, according to background information in the article.
To assess how the widely known system of self-regulation is doing, these researchers surveyed almost 1900 anesthesiologists, cardiologists, pediatricians, psychiatrists and forebears medicine, general surgery and internal medicine doctors. Physicians were asked if, within the recent three years, they had had "direct, personal knowledge of a physician who was impaired or inexpert to practice medicine" and if they had reported that colleague.
Of 17 percent of doctors who had direct awareness of an incompetent colleague, only two-thirds actually reported the problem, the survey found. This without considering the fact that 64 percent of all respondents agreed that physicians should report impaired colleagues. Almost 70 percent of physicians felt they were "prepared" to account such a problem, the study authors noted.
New Methods Of Fight Against Excess Weight
New Methods Of Fight Against Excess Weight.
Few situations can stagger up someone who is watching their power like an all-you-can-eat buffet. But a new delve into letter published in the April 2013 issue of the American Journal of Preventive Medicine suggests two strategies that may worker dieters survive a smorgasbord: Picking up a smaller plate and circling the buffet before choosing what to eat. Buffets have two things that nurture nutritionists' eyebrows - limitless portions and tons of choices. Both can crank up the calorie count of a meal.
So "Research shows that when faced with a category of food at one sitting, people tend to eat more. It is the seducing of wanting to try a variety of foods that makes it particularly hard not to overeat at a buffet," says Rachel Begun, a registered dietitian and spokeswoman for the Academy of Nutrition and Dietetics.
She was not twisted with the experimental study. Still, some people don't overeat at buffets, and that made study initiator Brian Wansink, director of the food and brand lab at Cornell University in Ithaca, NY, sight how they restrain themselves. "People often say that the only way not to overeat at a buffet is not to go to a buffet a psychologist who studies the environmental cues linked to overeating.
But there are a ton of the crowd at buffets who are really skinny. We wondered: What is it that lank people do at buffets that heavy people don't?" Wansink deployed a rig of 30 trained observers who painstakingly collected information about the eating habits of more than 300 society who visited 22 all-you-can-eat Chinese buffet restaurants in six states.
Tucked away in corners where they could heed unobtrusively, the observers checked 103 different things about the way multitude behaved around the buffet. They logged information about whom diners were with and where they sat - close or far from the buffet, in a food or booth, facing toward or away from the buffet. Observers also noted what kind of utensils diners old - forks or chopsticks - whether they placed a napkin in their laps, and even how many times they chewed a lone mouthful of food.
They also were taught to estimate a person's body-mass index, or BMI, on sight. Body-mass list is the ratio of a person's weight to their height, and doctors use it to gauge whether a person is overweight. The results of the contemplation revealed key differences in how thinner and heavier people approached a buffet.
Few situations can stagger up someone who is watching their power like an all-you-can-eat buffet. But a new delve into letter published in the April 2013 issue of the American Journal of Preventive Medicine suggests two strategies that may worker dieters survive a smorgasbord: Picking up a smaller plate and circling the buffet before choosing what to eat. Buffets have two things that nurture nutritionists' eyebrows - limitless portions and tons of choices. Both can crank up the calorie count of a meal.
So "Research shows that when faced with a category of food at one sitting, people tend to eat more. It is the seducing of wanting to try a variety of foods that makes it particularly hard not to overeat at a buffet," says Rachel Begun, a registered dietitian and spokeswoman for the Academy of Nutrition and Dietetics.
She was not twisted with the experimental study. Still, some people don't overeat at buffets, and that made study initiator Brian Wansink, director of the food and brand lab at Cornell University in Ithaca, NY, sight how they restrain themselves. "People often say that the only way not to overeat at a buffet is not to go to a buffet a psychologist who studies the environmental cues linked to overeating.
But there are a ton of the crowd at buffets who are really skinny. We wondered: What is it that lank people do at buffets that heavy people don't?" Wansink deployed a rig of 30 trained observers who painstakingly collected information about the eating habits of more than 300 society who visited 22 all-you-can-eat Chinese buffet restaurants in six states.
Tucked away in corners where they could heed unobtrusively, the observers checked 103 different things about the way multitude behaved around the buffet. They logged information about whom diners were with and where they sat - close or far from the buffet, in a food or booth, facing toward or away from the buffet. Observers also noted what kind of utensils diners old - forks or chopsticks - whether they placed a napkin in their laps, and even how many times they chewed a lone mouthful of food.
They also were taught to estimate a person's body-mass index, or BMI, on sight. Body-mass list is the ratio of a person's weight to their height, and doctors use it to gauge whether a person is overweight. The results of the contemplation revealed key differences in how thinner and heavier people approached a buffet.
Monday, 2 October 2017
US Doctors Confirm The Correct Solution To The Problem Of Epilepsy
US Doctors Confirm The Correct Solution To The Problem Of Epilepsy.
The tremendous seniority of epilepsy patients who have brain surgery to upon the seizure disorder find it improves their mood and their ability to work and drive, a new analysis reveals. Meanwhile, a second study also indicates the procedure is safe and effective for patients over 60. "They're both reassuring findings," said Bruce Hermann, top dog of the Charles Matthews Neuropsychology Lab at the University of Wisconsin School of Medicine and Public Health. "Epilepsy is a unfavourable snarl to have and live with, coming with a high rate of depression and affecting the ability to drive and work.
And "We always hoped surgery would have cheerful effects on patients' life situations, and this research does show that, and shows that the outcomes persist," added Hermann, who was not intricate with the research Dec 2013. Both studies are scheduled to be presented Sunday at the American Epilepsy Society annual converging in Washington, DC Research presented at ordered conferences is considered preliminary until published in a peer-reviewed medical journal.
Affecting about 2,2 million Americans and 65 million man globally, epilepsy is a annexation disorder triggered by abnormal nerve cell signaling in the brain, according to the Epilepsy Foundation. More than 1 million Americans with epilepsy take from treatment-resistant seizures that can hamper their ability to drive, effect and learn. Epilepsy is the third most common neurological disorder, after Alzheimer's disease and stroke.
The tremendous seniority of epilepsy patients who have brain surgery to upon the seizure disorder find it improves their mood and their ability to work and drive, a new analysis reveals. Meanwhile, a second study also indicates the procedure is safe and effective for patients over 60. "They're both reassuring findings," said Bruce Hermann, top dog of the Charles Matthews Neuropsychology Lab at the University of Wisconsin School of Medicine and Public Health. "Epilepsy is a unfavourable snarl to have and live with, coming with a high rate of depression and affecting the ability to drive and work.
And "We always hoped surgery would have cheerful effects on patients' life situations, and this research does show that, and shows that the outcomes persist," added Hermann, who was not intricate with the research Dec 2013. Both studies are scheduled to be presented Sunday at the American Epilepsy Society annual converging in Washington, DC Research presented at ordered conferences is considered preliminary until published in a peer-reviewed medical journal.
Affecting about 2,2 million Americans and 65 million man globally, epilepsy is a annexation disorder triggered by abnormal nerve cell signaling in the brain, according to the Epilepsy Foundation. More than 1 million Americans with epilepsy take from treatment-resistant seizures that can hamper their ability to drive, effect and learn. Epilepsy is the third most common neurological disorder, after Alzheimer's disease and stroke.
Subscribe to:
Posts (Atom)